Sectoral Funds – Weekly roundup - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sectoral Funds – Weekly roundup

Jul 8, 2000

This week witnessed the BSE Sensex posting 3.3% appreciation. The last few weeks have seen a revival in old economy stocks with the new economy taking a backseat for a change. However, this does not prevent IT funds from outperforming the others.

Open-ended, IT FundsNAV
(Rs)
Last
week
Last
month
Last
year
Since
inception
UTI Sector- Software25.604.30%12.30%0.00%96.20%
DSP ML Tech.com (Gr)10.094.20%7.20%0.00%18.10%
K P Internet Opport.(Gr)9.014.00%5.30%0.00%-5.90%
K P Infotech (Gr)32.333.60%9.10%218.20%180.30%
Magnum Sector Funds-IT17.713.00%9.20%0.00%148.20%
K Tech8.562.60%6.20%0.00%9.20%
IL&FS eCOM Fund (Gr)7.782.20%11.60%0.00%-42.90%
Birla IT Fund (Gr)22.852.20%4.80%102.00%18.20%
Chola Freedom Tech (Cum)17.751.40%9.40%28.30%25.40%
Pru ICICI Tech. (Gr)6.591.10%5.90%0.00%-33.00%
Alliance New Millenn (Gr)9.601.10%6.10%0.00%-37.20%
Tata IT Sector Fund13.790.90%6.70%119.60%29.90%
Sun F&C Emerg Tech (Gr)7.610.50%4.40%0.00%-11.10%

IT funds continued to see rapid growth. With the run-up in the prices of Infosys and Satyam (the cornerstone of most portfolios) IT funds continued to do well. All funds in this category witnessed growth over the week and the month. UTI’s Software fund was the star performer brushing aside misconceptions that private funds are better performers vis-ŕ-vis public sector funds.

Open-ended, Pharma FundsNAV
(Rs)
Last
week
Last
month
Last
year
Since
inception
Magnum Sector Funds-Pharma10.163.10%5.40%0.00%0.90%
K P Pharma (Gr)10.262.30%1.90%8.50%8.10%
UTI Sector-Pharma10.511.60%3.40%0.00%-11.90%

Pharma funds also witnessed NAV appreciation. Indian pharma stocks (Ranbaxy, Cipla, Dr Reddy) had some role to play in this. MNC pharma stocks remained steady. Buying by retail investors and institutions implies that there is appetite for pharma stocks. SBI’s Magnum Pharma was the outperformer over the week and the month.

Open-ended, FMCG FundsNAV
(Rs)
Last
week
Last
month
Last
year
Since
inception
Magnum Sector Funds-FMCG8.971.80%3.00%0.00%-13.10%
K P FMCG (Gr) 12.010.80%2.00%10.40%18.60%
Pru ICICI FMCG (Gr)10.030.60%3.50%-4.70%-2.30%

Performance of FMCG funds’ can at best be described as staid, compared to IT and pharma. However, all FMCG funds were in the positive over the week. The reasons are not hard to find – all FMCG funds have taken large exposures to Hindustan Lever which is on a roll. (Incidentally Hindustan Lever went ex-split this week and buying interest continued to remain high).

As in pharma, SBI’s Magnum FMCG was most impressive over the week and the month. However, it improved over a much lower base, when compared to Kothari FMCG and Pru-ICICI FMCG.

Public sector funds seem to be creeping into the limelight very slowly. This is evident from the fact that all the three sectoral star performers (UTI and SBI MF) were from the public sector.


Equitymaster requests your view! Post a comment on "Sectoral Funds – Weekly roundup". Click here!

  

More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

My Top Stock to Buy in this Market Selloff (Profit Hunter)

Sep 22, 2020

The recent correction offers a great opportunity to buy this high conviction smallcap stock.

Can the Nifty Fall to 10,200? (Fast Profits Daily)

Sep 24, 2020

The Nifty has reached an important support level today. If it breaks then we could see further downside.

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

MARKET STATS